Table 2.
Aberrant Imprinting in Human Cancer
| Tumor type | Gene | Reference |
|---|---|---|
| Childhood Tumors | ||
| Wilms’ tumor | IGF2,H19,p57KIP2,M6P/IGF2R | 63, 113, 139, 162 |
| Rhabdomyosarcoma | IGF2 | 203 |
| Ewing’s sarcoma | IGF2 | 204 |
| Hepatoblastoma | IGF2 | 205, 206 |
| Adult Tumors | ||
| Bladder | IGF2,H19,IPW | 207, 208 |
| Breast | IGF2 | 209, 210 |
| Cervical | IGF2,H19 | 211 |
| Choriocarcinoma | IGF2,H19 | 212 |
| Colorectal | IGF2 | 213 |
| Esophageal | H19 | 214 |
| Gastric adenocarcinoma | IGF2 | 215 |
| Glioma | IGF2 | 216 |
| Hepatocellular | IGF2,H19 | 217, 218 |
| Leukemia-acute myeloid | IGF2 | 219 |
| Leukemia-chronic myelogenous | IGF2 | 220 |
| Lung | IGF2,H19,p73 | 221–223 |
| Medulloblastoma | IGF2,H19 | 224 |
| Mesothelioma | IGF2 | 225 |
| Ovarian | IGF2 | 226 |
| Prostate | IGF2 | 227 |
| Renal cell carcinoma | IGF2,p73 | 148, 228 |
| Testicular germ cell | IGF2,H19 | 229 |
| Uterine | IGF2 | 230 |